Pulmonary disease during the treatment of rheumatoid arthritis with low dose pulse methotrexate.
about
Safety of non-steroidal anti-inflammatory drugs, including aspirin and paracetamol (acetaminophen) in people receiving methotrexate for inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritiLife threatening acute pneumonitis during low dose methotrexate treatment for rheumatoid arthritis: a case report and review of the literature.Methotrexate-related pulmonary complications in patients with rheumatoid arthritis: cluster of five cases in a period of three months.Successful reintroduction of methotrexate after pneumonitis in two patients with rheumatoid arthritis.Pulmonary toxicity in a patient with psoriasis receiving methotrexate therapy.Combination therapy for autoimmune diseases: the rheumatoid arthritis model.Carvacrol and pomegranate extract in treating methotrexate-induced lung oxidative injury in ratsHow common is methotrexate pneumonitis? A large prospective study investigates.Will pharmacogenetics allow better prediction of methotrexate toxicity and efficacy in patients with rheumatoid arthritis?Effects of a biologic agent in a patient with rheumatoid arthritis after treatment for methotrexate-associated B-cell lymphoma: a case report.Acute pneumonitis associated with low dose methotrexate treatment for rheumatoid arthritis: report of five cases and review of published reports.Factors associated with toxicity, final dose, and efficacy of methotrexate in patients with rheumatoid arthritis.Bronchoalveolar lavage cell profile in methotrexate induced pneumonitisMethotrexate induced lung injury in a patient with primary CNS lymphoma: a case report.Multinational evidence-based recommendations for pain management by pharmacotherapy in inflammatory arthritis: integrating systematic literature research and expert opinion of a broad panel of rheumatologists in the 3e Initiative.Methotrexate-induced pneumonitis in Crohn's disease. Case report and review of the literatureThe use of disease modifying antirheumatic drugs in the management of rheumatoid arthritis.An update on methotrexate pharmacogenetics in rheumatoid arthritis.Methotrexate-induced pulmonary toxicity in psoriatic arthritis (PsA): case presentation and literature review.Lung involvement and drug-induced lung disease in patients with rheumatoid arthritis.Methotrexate: an old new drug in autoimmune disease.Cytomegalovirus pneumonia in a patient with rheumatoid arthritis treated with low dose methotrexate and prednisone.Methotrexate-related pulmonary complications in rheumatoid arthritis.Metaanalysis of methylenetetrahydrofolate reductase (MTHFR) polymorphisms affecting methotrexate toxicity.Clinical, Epidemiological, and Histopathological Features of Respiratory Involvement in Rheumatoid Arthritis.Progressive pulmonary infiltrates in a patient with polymyositis.Methotrexate and lung disease in rheumatoid arthritis: a meta-analysis of randomized controlled trials.The C677T polymorphism in theMTHFRgene is associated with the toxicity of methotrexate in a Spanish rheumatoid arthritis population
P2860
Q24235194-DEEC8BEB-9DE9-46AA-91DC-C17E41155EE7Q33561110-FD3C22A4-A559-4047-8FFE-4D1AC87EF7C8Q33566508-3D801184-A7E2-47AD-9878-B6B3DC476A61Q33567526-0515E999-704A-4364-A13E-18CCBEEF43E4Q33836082-6A998176-31B2-43DD-8E56-0A515AA1AC7FQ34309751-2A4F1F10-B0BA-4540-88B9-B869571A7B37Q34413614-DFCD5B16-CBDA-4D2A-A554-751CF91E3706Q34629827-8889A58E-04C9-47A5-9DBC-ABA9AF759A31Q35024962-63E67BD1-66C1-464F-8547-BDA33A0CB9C2Q35144770-4DFD4EAA-9E5A-42AE-B593-EEDF5268F1BDQ35428302-973A8D02-9FFB-4467-9635-654AE9BF62C0Q35552661-2AC47930-CD44-4DBD-8FED-82F7C07AD826Q35563531-AD8A9378-D0B2-4D3A-B48B-277D27F49A3BQ35924725-1DE1C592-4C32-4412-BD14-E36844C10781Q36096803-D1CF3A29-6132-4612-AD1C-537900C535FBQ36293824-864A55C9-E287-4E7F-A25E-9B7E13918D33Q36723705-DD53C6CB-C9A7-48A1-A6CE-7EAB397C0289Q37126658-11B493FD-AE2C-4F92-8A1C-7CA95A8E155FQ37879966-86B7D281-B0FF-4294-B37B-8E66A7DCC15BQ38125245-676434BF-1462-4E36-8CFC-893F026A3040Q38253237-514B0FD0-FE59-4E6C-B475-60A447CDD749Q41232124-415108B7-134A-4B71-AD5E-3D5DCB9699B3Q41275873-AC99B0AF-8DC4-4038-B8F5-D4B4E85ADAB3Q41808826-A342BF68-B9AA-41BF-A487-EF714C6C870EQ45903141-55E2EDD5-84A4-475F-A7BF-352B9C2AE102Q46104189-20AE1710-47E4-4BAB-A119-9808894B2395Q51728375-F179AA24-266D-4E0A-ACF9-4A58630FC837Q58912366-22E94086-2B84-4419-B6B0-917863AEFC60
P2860
Pulmonary disease during the treatment of rheumatoid arthritis with low dose pulse methotrexate.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
1987年學術文章
@zh
1987年學術文章
@zh-hant
name
Pulmonary disease during the t ...... h low dose pulse methotrexate.
@en
Pulmonary disease during the t ...... h low dose pulse methotrexate.
@nl
type
label
Pulmonary disease during the t ...... h low dose pulse methotrexate.
@en
Pulmonary disease during the t ...... h low dose pulse methotrexate.
@nl
prefLabel
Pulmonary disease during the t ...... h low dose pulse methotrexate.
@en
Pulmonary disease during the t ...... h low dose pulse methotrexate.
@nl
P2093
P1476
Pulmonary disease during the t ...... h low dose pulse methotrexate.
@en
P2093
P304
P356
10.1016/0049-0172(87)90021-7
P577
1987-02-01T00:00:00Z